Industry Reports

Emerging tech will see highest level of investment in life sciences in the next 12 months, finds survey from the Pistoia Alliance conference

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences and healthcare R&D, announced findings from a survey conducted at its spring conference. Respondents believe that emerging technologies including AI and blockchain will receive...

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest...

Press Ganey Report on Health Care Safety Culture Prior to and During the COVID-19 Pandemic Finds Downward Trend Continues

Press Ganey released its newest research brief, Reverse the Trend: Improving Safety Culture in the COVID-19 Era. Analyses of national safety culture data and trends prior to and during the COVID-19 pandemic reveal that after a period of modest...

CPhI Report forecasts explosion of contract services growth due to surging INDs and 75 FDA approvals by 2025

A post-pandemic pharma report from CPhI predicts the next few years will deliver strong growth in pharma innovation, with oncology and rare diseases potentially the biggest beneficiaries of positive covid legacies – including accelerated development timelines, remote trials and...

Etihad Cargo Reports 50% Y-O-Y Rise in Pharma Shipments

Etihad Cargo, the cargo and logistics arm of Abu Dhabi-based Etihad Aviation Group, has reported a 50 per cent year-on-year rise in pharma shipments under its specialised PharmaLife product. The double-digit annual growth comes as the carrier marks its second...

Biopharma Market Worth $546.6 billion by 2027

Biopharma market was valued at approximately USD 244.1 Billion in 2019 and is expected to generate revenue of around USD 546.6 Billion by end of 2027, growing at a CAGR of around 10.6% between 2020 and 2027 Market Overview...

Uni-Bio Science Group Announces 2020 Interim Results

A fully integrated biopharmaceutical company - Uni-Bio Science Group Limited, is pleased to announce its interim results for six months ended 30 June 2020 (the "Period"). During the Period, the Group recorded a turnover of HK$67.4 million, representing a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read